{"cik":"0001836295","entityName":"RETINALGENIX TECHNOLOGIES INC.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-11-17","val":42155654,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q4I"}]}}},"us-gaap":{"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":141431,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":210873,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2020-12-31","val":2840599,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":4277676,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":{"label":"APIC, Share-based Payment Arrangement, Increase for Cost Recognition","description":"Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":55051,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q1"},{"start":"2020-04-01","end":"2020-06-30","val":55051,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q2"},{"start":"2020-07-01","end":"2020-09-30","val":55051,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":111487,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1"},{"start":"2021-04-01","end":"2021-06-30","val":86329,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":55051,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts":{"label":"Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs","description":"Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.","units":{"USD":[{"start":"2021-07-01","end":"2021-09-30","val":70994,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities":{"label":"Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities","description":"The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":414174,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-01-01","end":"2021-09-30","val":893150,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"AdministrativeFeesExpense":{"label":"Administrative Fees Expense","description":"Amount of expense for administrative services provided to the limited liability company (LLC) or limited partnership (LP) by the managing member or general partner, affiliate of managing member or general partner, or affiliate of LLC or LP, for example, but not limited to, salaries, rent, or overhead costs.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1077450,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":413151,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":949945,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":293893,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":61075,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":36578,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":61075,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":36578,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2019-12-31","val":54381,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2019Q4I"},{"end":"2020-09-30","val":30090,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3I"},{"end":"2020-12-31","val":2219,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":36578,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect","description":"Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-24291,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-01-01","end":"2021-09-30","val":34359,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"CommonStockCapitalSharesReservedForFutureIssuance":{"label":"Common Stock, Capital Shares Reserved for Future Issuance","description":"Aggregate number of common shares reserved for future issuance.","units":{"shares":[{"end":"2021-09-30","val":5680000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2018-01-08","val":0.0001,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2017Q4I"},{"end":"2020-12-31","val":0.0001,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0.0001,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2018-01-08","val":80000000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2017Q4I"},{"end":"2020-12-31","val":80000000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":80000000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":40678323,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":41933654,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":40678323,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":41933654,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":4067,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":4194,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"CostsAndExpenses":{"label":"Costs and Expenses","description":"Total costs of sales and operating expenses for the period.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":87785,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-01-01","end":"2021-09-30","val":34510,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"DeferredOfferingCosts":{"label":"Deferred Offering Costs","description":"Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.","units":{"USD":[{"end":"2020-12-31","val":43787,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"}]}},"DeferredTaxAssetsNet":{"label":"Deferred Tax Assets, Net of Valuation Allowance","description":"Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.","units":{"USD":[{"end":"2019-12-31","val":232000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2019Q4I"},{"end":"2020-12-31","val":788000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"}]}},"DueFromRelatedPartiesCurrent":{"label":"Due from Related Parties, Current","description":"The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).","units":{"USD":[{"end":"2020-12-31","val":15069,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"}]}},"DueToRelatedPartiesCurrent":{"label":"Due to Related Parties, Current","description":"Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2021-09-30","val":164233,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":-0.04,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":-0.01,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-0.04,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":-0.01,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized":{"label":"Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount","description":"Amount of cost not yet recognized for nonvested award under share-based payment arrangement.","units":{"USD":[{"end":"2021-09-30","val":688000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"IncomeTaxExaminationPenaltiesAndInterestAccrued":{"label":"Income Tax Examination, Penalties and Interest Accrued","description":"The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"IncreaseDecreaseInAccountsPayable":{"label":"Increase (Decrease) in Accounts Payable","description":"The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":12282,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-01-01","end":"2021-09-30","val":69446,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"IncreaseDecreaseInInterestPayableNet":{"label":"Increase (Decrease) in Interest Payable, Net","description":"The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":1180,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"InterestExpense":{"label":"Interest Expense","description":"Amount of the cost of borrowed funds accounted for as interest expense.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":1180,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":1180,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"InterestPayableCurrent":{"label":"Interest Payable, Current","description":"Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2021-09-30","val":1180,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2020-12-31","val":141431,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":449286,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":61075,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":36578,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"LoansPayableCurrent":{"label":"Loans Payable, Current","description":"Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.","units":{"USD":[{"end":"2021-09-30","val":73000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1026331,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-01-01","end":"2021-09-30","val":910765,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-1050622,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-01-01","end":"2021-09-30","val":-876406,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-466837,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q1"},{"start":"2020-04-01","end":"2020-06-30","val":-430861,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":-1464796,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":-567098,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":-683681,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1"},{"start":"2021-04-01","end":"2021-06-30","val":-534852,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-1769556,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":-551023,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1464796,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":567098,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":1768376,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":549843,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"OperatingLossCarryforwards":{"label":"Operating Loss Carryforwards","description":"Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.","units":{"USD":[{"end":"2020-12-31","val":2058000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"}]}},"OtherNoncashExpense":{"label":"Other Noncash Expense","description":"Amount of expense or loss included in net income that result in no cash flow, classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":236739,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-01-01","end":"2021-09-30","val":569657,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"PreferredStockParOrStatedValuePerShare":{"label":"Preferred Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.","units":{"USD/shares":[{"end":"2018-01-08","val":0.0001,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2017Q4I"},{"end":"2020-12-31","val":0.0001,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0.0001,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"PreferredStockSharesAuthorized":{"label":"Preferred Stock, Shares Authorized","description":"The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2018-01-08","val":40000000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2017Q4I"},{"end":"2020-12-31","val":40000000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":40000000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"PreferredStockSharesIssued":{"label":"Preferred Stock, Shares Issued","description":"Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.","units":{"shares":[{"end":"2020-12-31","val":3000000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":3000000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"PreferredStockSharesOutstanding":{"label":"Preferred Stock, Shares Outstanding","description":"Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.","units":{"shares":[{"end":"2020-12-31","val":3000000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":3000000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"PreferredStockSharesSubscribedButUnissuedSubscriptionsReceivable":{"label":"Preferred Stock, Shares Subscribed but Unissued, Subscriptions Receivable","description":"Amount of subscription receivable from investors who have been allocated nonredeemable preferred stock or preferred stock redeemable solely at the option of the issuer.","units":{"USD":[{"end":"2020-12-31","val":300,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":300,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"PreferredStockValue":{"label":"Preferred Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":300,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":300,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"ProceedsFromIssuanceOfCommonStock":{"label":"Proceeds from Issuance of Common Stock","description":"The cash inflow from the additional capital contribution to the entity.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1051331,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-01-01","end":"2021-09-30","val":824265,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"ProceedsFromRelatedPartyDebt":{"label":"Proceeds from Related Party Debt","description":"The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":73000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"ProceedsFromWarrantExercises":{"label":"Proceeds from Warrant Exercises","description":"The cash inflow associated with the amount received from holders exercising their stock warrants.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":13500,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"RelatedPartyCosts":{"label":"Related Party Costs","description":"Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1248154,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-01-01","end":"2021-09-30","val":750639,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"RepaymentsOfRelatedPartyDebt":{"label":"Repayments of Related Party Debt","description":"The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1099200,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-01-01","end":"2021-09-30","val":215489,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":222193,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":98896,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":565564,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":200899,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-2925022,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":-4694578,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":165153,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":55051,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":252867,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":55051,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate","description":"The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.","units":{"pure":[{"start":"2020-01-01","end":"2020-12-31","val":0,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate","description":"The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.","units":{"pure":[{"start":"2020-01-01","end":"2020-12-31","val":0.731,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate","description":"The risk-free interest rate assumption that is used in valuing an option on its own shares.","units":{"pure":[{"start":"2020-01-01","end":"2020-12-31","val":0.0242,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised","description":"Number of non-option equity instruments exercised by participants.","units":{"shares":[{"start":"2021-01-01","end":"2021-09-30","val":13500,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted","description":"Net number of non-option equity instruments granted to participants.","units":{"shares":[{"start":"2021-01-01","end":"2021-09-30","val":150000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number","description":"Number of equity instruments other than options outstanding, including both vested and non-vested instruments.","units":{"shares":[{"end":"2019-12-31","val":62500,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2019Q4I"},{"end":"2020-12-31","val":62500,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":199000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number","description":"The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.","units":{"shares":[{"end":"2020-12-31","val":405000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":605000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures","description":"Net number of share options (or share units) granted during the period.","units":{"shares":[{"start":"2021-01-01","end":"2021-09-30","val":20000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2019-12-31","val":1800000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2019Q4I"},{"end":"2020-12-31","val":1800000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1820000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price","description":"Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.","units":{"USD/shares":[{"end":"2019-12-31","val":1,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2019Q4I"},{"end":"2020-12-31","val":1,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price","description":"Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-09-30","val":1,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"SharePrice":{"label":"Share Price","description":"Price of a single share of a number of saleable stocks of a company.","units":{"USD/shares":[{"end":"2020-12-31","val":1,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2019-12-31","val":24164,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2019Q4I"},{"end":"2020-03-31","val":-10622,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q1I"},{"end":"2020-06-30","val":-128762,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q2I"},{"end":"2020-09-30","val":133975,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3I"},{"end":"2020-12-31","val":-80356,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-254453,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1I"},{"end":"2021-06-30","val":-35742,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q2I"},{"end":"2021-09-30","val":-412708,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"StockIssued1":{"label":"Stock Issued","description":"The fair value of stock issued in noncash financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":358126,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-01-01","end":"2021-09-30","val":390358,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"}]}},"StockIssuedDuringPeriodValueNewIssues":{"label":"Stock Issued During Period, Value, New Issues","description":"Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":377000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q1"},{"start":"2020-04-01","end":"2020-06-30","val":257670,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q2"},{"start":"2020-07-01","end":"2020-09-30","val":416658,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":398097,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q1"},{"start":"2021-04-01","end":"2021-06-30","val":263376,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":190000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}},"StockIssuedDuringPeriodValueOther":{"label":"Stock Issued During Period, Value, Other","description":"Value of shares of stock issued attributable to transactions classified as other.","units":{"USD":[{"start":"2021-04-01","end":"2021-06-30","val":13500,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q2"}]}},"UnrecognizedTaxBenefits":{"label":"Unrecognized Tax Benefits","description":"Amount of unrecognized tax benefits.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3I"}]}},"ValuationAllowanceDeferredTaxAssetChangeInAmount":{"label":"Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount","description":"Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.","units":{"USD":[{"start":"2019-01-01","end":"2019-12-31","val":232000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2019"},{"start":"2020-01-01","end":"2020-12-31","val":556000,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":39507084,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2020-07-01","end":"2020-09-30","val":39996806,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":41303545,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22"},{"start":"2021-07-01","end":"2021-09-30","val":41825154,"accn":"0001493152-21-029613","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-22","frame":"CY2021Q3"}]}}}}}